Related Experiment Video
Updated: Aug 30, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
Defensive applications of gene transfer technology in the face of bioterrorism: DNA-based vaccines and immune
Catherine J Ackley1, Michael R Greene, Christopher H Lowrey
1Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, NH 03755-1404, USA.
Abstract:
Gene transfer involves the introduction of an engineered gene into a person's cells with the expectation that the protein expressed from the gene will produce a therapeutic benefit. Strategies based on this principle have led to the approval of > 600 clinical trials and enrollment of approximately 3500 subjects worldwide in attempts to treat diseases ranging from cancer to AIDS to cystic fibrosis. While gene therapy has met with limited success and still has many hurdles to overcome before it sees wide application, it may be useful as a defensive strategy against bioterrorism agents including infectious microbes and toxins. Although many defensive strategies are possible, immunological strategies are currently the most developed and are being actively applied to the development of strategies against several of the most virulent potential bio-weapons. While most of these strategies are not yet ready for human application, DNA-based vaccines appear to be among the most promising in the fight against bioterrorism.
Related Concept Videos
Recombinant DNA Technology
Gene Therapy
Gene Therapy
Microorganisms in Medicine and Therapeutics
What is Genetic Engineering?
In-vitro Mutagenesis (Gene Knockouts)

